Journal article

Development of subcutaneous Allergen Immunotherapy (Part 2): preventive Aspects of SCIT and Innovations


Authors list: Klimek, Ludger; Brehler, Randolf; Hamelmann, Eckard; Kopp, Matthias; Ring, Johannes; Treudler, Regina; Jakob, Thilo; Worm, Margitta; Pfaar, Oliver

Publication year: 2019

Pages: 31-46

Journal: Allergo-Journal

Volume number: 28

Issue number: 4

ISSN: 0941-8849

eISSN: 2195-6405

DOI Link: https://doi.org/10.1007/s15007-019-1847-4

Publisher: SPRINGER HEIDELBERG



Citation Styles

Harvard Citation style: Klimek, L., Brehler, R., Hamelmann, E., Kopp, M., Ring, J., Treudler, R., et al. (2019) Development of subcutaneous Allergen Immunotherapy (Part 2): preventive Aspects of SCIT and Innovations, Allergo-Journal, 28(4), pp. 31-46. https://doi.org/10.1007/s15007-019-1847-4

APA Citation style: Klimek, L., Brehler, R., Hamelmann, E., Kopp, M., Ring, J., Treudler, R., Jakob, T., Worm, M., & Pfaar, O. (2019). Development of subcutaneous Allergen Immunotherapy (Part 2): preventive Aspects of SCIT and Innovations. Allergo-Journal. 28(4), 31-46. https://doi.org/10.1007/s15007-019-1847-4



Keywords

DOUBLE-BLIND; GRASS-POLLEN IMMUNOTHERAPY; HOUSE-DUST MITE; L-TYROSINE; MONOPHOSPHORYL-LIPID-A; RECOMBINANT ALLERGENS; SEASONAL RHINOCONJUNCTIVITIS

Last updated on 2025-02-04 at 06:57